The capacity of young national medicine regulatory authorities to ensure the quality of medicines: case of Rwanda

The capacity of young national medicine regulatory authorities to ensure the quality of medicines: case of Rwanda

Background Access to quality medicines is a global initiative to ensure universal health coverage. However, the limited capacity of National Medicines Regulatory Authorities (NMRAs) to prevent and detect the supply of poor-quality medicines led to the predominance of sub-standard and falsified (SF)...

Full description

Bibliographic Details
Main Authors: Jean Baptiste B. Shabani, Egide Kayitare, Eric Nyirimigabo, Vedaste Habyalimana, Marilyn M. Murindahabi, Lazare Ntirenganya, Clarisse Irasabwa, Eugene Rutungwa, Jose Edouard Munyangaju, Innocent Hahirwa
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
poor-quality medicines
falsified medicines
substandard medicines
medicines regulatory practices
healthcare supply chain
rwanda fda
Online Access:http://dx.doi.org/10.1186/s40545-022-00492-2

Internet

http://dx.doi.org/10.1186/s40545-022-00492-2

Similar Items